NEWSBRIEF: Gene Logic Reports Widened Revenue, Narrowed Loss, Contracted R&D in Q1

Apr 29, 2002

NEW YORK, April 29 - Gene Logic today reported wider revenue and a narrower first-quarter loss as it racked up more pharma and biotech subscribers.

Revenue for the period ended March 31 rose to $11.8 million from $8.2 million, and net loss narrowed to $7.5 million, or $.28 a share, from $10.6 million, or $.40 per share, one year ago.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Silencing for Preeclampsia

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

Settlement Expected in Duke Case

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

This Week in PNAS

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

Something Different

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.

Main menu